Rapid Micro Biosystems (RPID) Change in Account Payables (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Change in Account Payables of $530000.0 for Q1 2026, up 430.0% on a YoY basis from $100000.0 in Q1 2025, and down 3.46% sequentially from $549000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Change in Account Payables (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Change in Account Payables data on file, last reported at $530000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 430.0% year-over-year to $530000.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (up 38.0% YoY), and the FY2025 full-year result was $1.6 million, up 184.7% from the prior year.
- Change in Account Payables eased to $530000.0 in Q1 2026, from $549000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.9 million in Q3 2023 to a low of -$4.1 million in Q1 2023.
- A 5-year average of $42411.8 and a median of $205000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables tumbled 1037.5% in 2022 and jumped 1219.48% in 2024, its largest moves.
- Tracing RPID's Change in Account Payables over 5 years: stood at $1.8 million in 2022, then tumbled by 173.79% to -$1.3 million in 2023, then surged by 115.79% to $205000.0 in 2024, then soared by 167.8% to $549000.0 in 2025, then slipped by 3.46% to $530000.0 in 2026.
- Business Quant data shows RPID's Change in Account Payables at $530000.0 in Q1 2026, $549000.0 in Q4 2025, and $251000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 530,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 530,000.00 |
| Mar 31, 2026 | 530,000.00 |
| Dec 31, 2025 | 549,000.00 |
| Dec 31, 2025 | 549,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -809,000.00 |
| Mar 31, 2024 | -809,000.00 |
| Dec 31, 2023 | -1.30 Mn |
| Dec 31, 2023 | -1.30 Mn |